# EDGAR Filing Document

**Accession Number:** 0001944285
**File Stem:** 0000894189-26-012697
**Filing Date:** 2026-4
**Character Count:** 21601
**Document Hash:** eef4fff29b75011dae384ad243b6e520
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-26-012697.hdr.sgml**: 20260423

**ACCESSION NUMBER**: 0000894189-26-012697

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260423

**DATE AS OF CHANGE**: 20260423

**PERIOD START**: 20260228

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tema ETF Trust
- **CENTRAL INDEX KEY:** 0001944285

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23823
- **FILM NUMBER:** 26887771

**BUSINESS ADDRESS:**
- **STREET 1:** 1919 M STREET, N.W., SUITE 700
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 3024994928 EXT. 801

**MAIL ADDRESS:**
- **STREET 1:** 1919 M STREET, N.W., SUITE 700
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

## Series and Classes Contracts Data

### Tema Oncology ETF (Series ID: S000078299)

| Class ID   | Class Name        | Ticker Symbol   |
|:---|:---|:---|
| C000239059 | Tema Oncology ETF | CANC            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Tema ETF Trust

- **b. Investment Company Act file number:** 811-23823

- **c. CIK number of Registrant:** 0001944285

- **d. LEI of Registrant:** 549300JKGDXNE2CLUY37

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 200 Vesey Street

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10281

  - **Telephone number:** 3024994928 EXT 801

**Item A.2. Information about the Series.**

- **a. Name of Series:** Tema Oncology ETF

- **b. EDGAR series identifier (if any):** S000078299

- **c. LEI of Series:** 549300N3IU4YD19QLF24

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-02-28

- **b. Date as of which information is reported:** 2026-02-28

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $159966656.56

**Total Liabilities:** $89111.80

**Net Assets:** $159877544.76

**Cash Not Reported:** $0.01

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000239059 | -2.81%               | 2.92%                | 5.77%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $78436.34                | $-3080823.74                               |
| Month 2  | $171402.37               | $3219435.73                                |
| Month 3  | $-171069.59              | $8736824.49                                |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                           | Title                                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co                  | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    108187 | NS      | $6747623.19   | 4.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc      | Halozyme Therapeutics Inc                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     29868 | NS      | $2076722.04   | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                           | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      6565 | NS      | $6906314.35   | 4.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Monte Rosa Therapeutics Inc    | Monte Rosa Therapeutics Inc              | CUSIP: 61225M102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45524 | NS      | $808051.00    | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc               | Nuvation Bio Inc                         | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    362046 | NS      | $2139691.86   | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                    | Novartis AG                              | CUSIP: N/A<br>LEI: 5493007HIVTX6SY6XD66       | Long             | EC               | CORP              | CH        |     46684 | NS      | $7923862.91   | 4.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                                | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     10122 | NS      | $3928955.52   | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                 | AnaptysBio Inc                           | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |     28657 | NS      | $1577567.85   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                    | Arcellx Inc                              | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48346 | NS      | $5501291.34   | 3.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc          | Arcus Biosciences Inc                    | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45953 | NS      | $936062.61    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                      | Argenx SE                                | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      1663 | NS      | $1275387.96   | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc         | ArriVent Biopharma Inc                   | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40743 | NS      | $935866.71    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                    | Arvinas Inc                              | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45326 | NS      | $601476.02    | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                     | AbbVie Inc                               | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     16712 | NS      | $3878520.96   | 2.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc           | Bridgebio Pharma Inc                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |    114318 | NS      | $7599860.64   | 4.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc         | Cogent Biosciences Inc                   | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    135358 | NS      | $5258658.30   | 3.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                        | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     16257 | NS      | $4038726.51   | 2.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd   | Chugai Pharmaceutical Co Ltd             | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |     30652 | NS      | $2052102.97   | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| BeOne Medicines Ltd            | BeOne Medicines Ltd                      | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | US        |      8960 | NS      | $2840230.40   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                          | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |     35320 | NS      | $7397860.46   | 4.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc      | Cullinan Therapeutics Inc                | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47065 | NS      | $729507.50    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                     | Erasca Inc                               | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    169487 | NS      | $2315192.42   | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                   | Exelixis Inc                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     79639 | NS      | $3508894.34   | 2.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc            | Guardant Health Inc                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     10008 | NS      | $939751.20    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                   | Immunome Inc                             | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    195451 | NS      | $4272558.86   | 2.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                   | Nuvalent Inc                             | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     49239 | NS      | $5019916.05   | 3.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Olema Pharmaceuticals Inc      | Olema Pharmaceuticals Inc                | CUSIP: 68062P106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     56608 | NS      | $1369913.60   | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc  | Regeneron Pharmaceuticals Inc            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      1982 | NS      | $1549269.94   | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc         | Relay Therapeutics Inc                   | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    142040 | NS      | $1457330.40   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyra Biosciences Inc           | Tyra Biosciences Inc                     | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28438 | NS      | $947269.78    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                     | Xencor Inc                               | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     76928 | NS      | $982370.56    | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Zai Lab Ltd                    | Zai Lab Ltd                              | CUSIP: 98887Q104<br>LEI: 549300P2UYQ9U5LY1T58 | Long             | EC               | CORP              | CN        |    121279 | NS      | $2330982.38   | 1.46%             |  |  |  | No            |                  1 | On Loan: No      |
| UroGen Pharma Ltd              | UroGen Pharma Ltd                        | CUSIP: N/A<br>LEI: 549300C0YCX7CG2G5D50       | Long             | EC               | CORP              | US        |     67164 | NS      | $1457458.80   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc                   | Celcuity Inc                             | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |     35371 | NS      | $3951294.41   | 2.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Corvus Pharmaceuticals Inc     | Corvus Pharmaceuticals Inc               | CUSIP: 221015100<br>LEI: 549300I3AVJ8F75NCX65 | Long             | EC               | CORP              | US        |     82148 | NS      | $1500022.48   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunocore Holdings PLC        | Immunocore Holdings PLC                  | CUSIP: 45258D105<br>LEI: 213800IUE3DFS84BVN18 | Long             | EC               | CORP              | GB        |     28275 | NS      | $913282.50    | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                     | Natera Inc                               | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      3049 | NS      | $634313.96    | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc       | Revolution Medicines Inc                 | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     98581 | NS      | $10057233.62  | 6.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                  | Zymeworks Inc                            | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     96723 | NS      | $2252678.67   | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                | CG oncology Inc                          | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45885 | NS      | $2698038.00   | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc | Day One Biopharmaceuticals Inc           | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    121928 | NS      | $1292436.80   | 0.81%             |  |  |  | No            |                  1 | On Loan: No      |
| HUTCHMED China Ltd             | HUTCHMED China Ltd                       | CUSIP: 44842L103<br>LEI: 2138006X34YDQ6OBYE79 | Long             | EC               | CORP              | HK        |     62129 | NS      | $890308.57    | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc         | Ideaya Biosciences Inc                   | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     89238 | NS      | $2873463.60   | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Summit Therapeutics Inc        | Summit Therapeutics Inc                  | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110918 | NS      | $1840129.62   | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Treasury Obliga | First American Treasury Obligations Fund | CUSIP: 31846V328<br>LEI: 549300UU586IAH2B8H03 | Long             | STIV             | RF                | US        |   1026901 | NS      | $1026900.56   | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Genmab A/S                     | Genmab A/S                               | CUSIP: 372303206<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |    169724 | NS      | $4996674.56   | 3.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      9272 | NS      | $1381064.40   | 0.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc         | Janux Therapeutics Inc                   | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47193 | NS      | $642296.73    | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                 | Merck & Co Inc                           | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     49630 | NS      | $6145186.60   | 3.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc         | Nurix Therapeutics Inc                   | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     97555 | NS      | $1557953.35   | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG               | Roche Holding AG                         | CUSIP: 771195104<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    108952 | NS      | $6488091.60   | 4.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc      | Terns Pharmaceuticals Inc                | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |     28018 | NS      | $1180118.16   | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Legend Biotech Corp            | Legend Biotech Corp                      | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | US        |    115409 | NS      | $2192771.00   | 1.37%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc       | ORIC Pharmaceuticals Inc                 | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     35407 | NS      | $476224.15    | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc     | Syndax Pharmaceuticals Inc               | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |    127353 | NS      | $2764833.63   | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Compass Therapeutics Inc       | Compass Therapeutics Inc                 | CUSIP: 20454B104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    127476 | NS      | $720239.40    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-04-22

**Name of Applicant:** Tema ETF Trust

**Signature:** /s/ Fred Teufel

**Name of Signer:** Fred Teufel

**Title:** Treasurer